(Q37958560)

25 August 2017

title

Intradermal fractional dose inactivated polio vaccine: a review of the literature (English)

1 reference

25 August 2017

0 references

1 reference

4

Yvonne Maldonado

1 reference

25 August 2017

Katherine S Nelson

1

1 reference

25 August 2017

Julia M Janssen

series ordinal

2

1 reference

25 August 2017

Stephanie B Troy

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

17 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

30

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

121-125

1 reference

Implications of a circulating vaccine-derived poliovirus in Nigeria.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

New strategies for the elimination of polio from India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Trial of a supplemental dose of four poliovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Fractional doses of inactivated poliovirus vaccine in Oman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Polio eradication: the OPV paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Why polio has not been eradicated in India despite many remedial interventions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Diplomacy and the polio immunization boycott in Northern Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Designing vaccines based on biology of human dendritic cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Intradermal hepatitis B vaccination: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Antibody response following intradermal or oral administration of formalinised poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Response to poliomyelitis vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

World wide experience with inactivated poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Immune response to intradermally injected inactivated poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Immune response of infants to inactivated poliovirus vaccine injected intradermally

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.018

10.1016/J.VACCINE.2011.11.018

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference